The aim of the study was to to evaluate the effect of sarpogrelate, a selective serotonin receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients with variant angina.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
200
Sarpogrelate 100mg twice a day
Atorvastatin 80mg daily
Hyoen-Cheol Gwon, MD,PhD
Seoul, South Korea
RECRUITINGErgonovine provocation test 12months later
Time frame: 1 year later
C-reactive protein lever 12months later
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.